Deep learning company Atomwise has raised $45 million in a Series A round to further its work to discover new drugs. The company uses artificial intelligence to analyze millions of compounds for their potential as medications and discover their effect on the human body.
Company raises $45M for AI-based medication research
Sign up for Sigma Xi SmartBrief
News on scientific research and innovation
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.